EUVIMEDEUVIMED entdecken
Crossref

Inhibition of GRK2 mitigates renal fibrosis via oxidative stress pathway

Jiangrui Cheng, Xiao Jiang, Qinxiang Deng, Lei Ni, Wanghui Lin, Wenmin Cao, Pei Ren, Bingfa Xu, Qingtong Wang, Jiajie Kuai, Yonggui Wu, Wei Wei und 1 weitere

European Journal of Pharmacology · 2025

DOI: 10.1016/j.ejphar.2025.177887 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Pharmacology, 2025. Verfasst von Jiangrui Cheng und 12 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Clinical Pharmacology, School of Pharmaceutical Sciences, Anhui Medical University, Key Laboratory of Anti-Inflammatory and Immune Medic…. Hauptthemen laut MEDLINE: G-Protein-Coupled Receptor Kinase 2, Oxidative Stress, Kidney, Protein Kinase Inhibitors. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: Natural Science Foundation of Anhui Province, Anhui Provincial Key Research and Development Plan, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Studies have shown that G protein-coupled receptor kinase 2 (GRK2) undergoes functional changes in various diseases. Therefore, in this study, we examined the role of GRK2 in renal fibrosis induced by unilateral ureteral occlusion (UUO) and ischaemia-reperfusion (I/R), and evaluated the protective effect of pharmacological inhibition of GRK2. METHODS: UUO or I/R models were generated in GRK2 knockdown (GRK2-KD), GRK2 conditional-knockdown (GRK2-CKd), and wild-type (WT) mice. Biochemical markers of renal function and histopathological features of renal tissues were evaluated to assess the extent of renal fibrosis and the protective effect of pharmacological GRK2 inhibition. Transforming growth factor beta (TGF-β) and hypoxia-reoxygenation (H/R) models were established in GRK2 knockout (GRK2-KO) cells in vitro. RESULTS: The UUO/I/R model mice exhibited pathological damage and increased expression of GRK2 and NADPH oxidase 4 (NOX4). Compared to the Control group, the GRK2-KD and GRK2-CKd groups presented notable amelioration of renal function and pathological features, reduced NOX4 and oxidative stress. In vitro studies revealed that knocking out GRK2 reduced NOX4 levels, ameliorated oxidative stress, moderated cellular epithelial-mesenchymal transition (EMT), improved levels of collagen Ⅰ, α-smooth muscle actin (α-SMA), and E-cadherin, as well as the cellular morphology. In addition, pharmacological treatment with GRK2-inhibitors (CP-25 or paroxetine) markedly improved UUO/I/R-induced fibrosis. CONCLUSIONS: Pharmacologically blocking GRK2 using CP-25 or paroxetine effectively alleviates renal fibrosis by regulating NOX4 and oxidative stress. GRK2 represents a potential target for the prevention and treatment of renal fibrosis and inflammation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

G-Protein-Coupled Receptor Kinase 2Oxidative StressKidneyProtein Kinase InhibitorsKidney DiseasesAnimalsFibrosisMiceMaleNADPH Oxidase 4Mice, Inbred C57BLMice, KnockoutSignal TransductionUreteral ObstructionDisease Models, AnimalReperfusion InjuryEpithelial-Mesenchymal Transition

Stichwörter der Autor:innen

Chronic kidney diseaseEpithelial-mesenchymal transitionGRK2NOX4Renal fibrosis

Substanzen

G-Protein-Coupled Receptor Kinase 2GRK2 protein, mouseNADPH Oxidase 4Protein Kinase InhibitorsNox4 protein, mouse

Autor:innen und Institutionen

  • Institute of Clinical Pharmacology, School of Pharmaceutical Sciences, Anhui Medical University, Key Laboratory of Anti-Inflammatory and Immune Medicine, Ministry of Education, Anhui Collaborative Innovation Centre of A…
  • Department of Nephrology, the First Affiliated Hospital of Anhui Medical University, China.
  • Department of Pharmacy, the Third Affiliated Hospital of Anhui Medical University, China.
  • Department of Nephrology, the First Affiliated Hospital of Anhui Medical University, China. Electronic address: wuyonggui@medmail.com.cn.

Förderung

  • Natural Science Foundation of Anhui Province
  • Anhui Provincial Key Research and Development Plan
  • National Natural Science Foundation of China
  • Anhui Medical University

Zitieren

APA

Cheng, J., Jiang, X., Deng, Q., Ni, L., Lin, W., Cao, W., Ren, P., Xu, B., Wang, Q., Kuai, J., Wu, Y., Wei, W., & Wang, C. (2025). Inhibition of GRK2 mitigates renal fibrosis via oxidative stress pathway. European Journal of Pharmacology. https://doi.org/10.1016/j.ejphar.2025.177887

Vancouver

Cheng J, Jiang X, Deng Q, Ni L, Lin W, Cao W, et al. Inhibition of GRK2 mitigates renal fibrosis via oxidative stress pathway. European Journal of Pharmacology. 2025. doi:10.1016/j.ejphar.2025.177887

BibTeX
@article{Cheng2025,
  author = {Cheng, Jiangrui and Jiang, Xiao and Deng, Qinxiang and Ni, Lei and Lin, Wanghui and Cao, Wenmin and Ren, Pei and Xu, Bingfa and Wang, Qingtong and Kuai, Jiajie and Wu, Yonggui and Wei, Wei and Wang, Chun},
  title = {Inhibition of GRK2 mitigates renal fibrosis via oxidative stress pathway},
  journal = {European Journal of Pharmacology},
  year = {2025},
  doi = {10.1016/j.ejphar.2025.177887}
}
Kostenlos starten →